临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (9): 769-774.

• 论著 •    下一篇

沉默PGAM1基因对食管癌细胞生物学功能的影响

  

  1. 1  450003  郑州  河南省人民医院病理科

    2  450003  河南省人民医院肿瘤科

  • 收稿日期:2018-06-05 修回日期:2018-07-31 出版日期:2018-09-30 发布日期:2018-11-28
  • 通讯作者: 孔令非 E-mail:Lfkong9@163.com

Experimental study on the biological function and mechanism of PGAM1 on esophageal cancer

  1. Department of Pathology, Henan Provincial People's Hospital, Zhengzhou 450003,China

  • Received:2018-06-05 Revised:2018-07-31 Online:2018-09-30 Published:2018-11-28
  • Contact: KONG Lingfei E-mail:Lfkong9@163.com

摘要:

目的   探讨沉默磷酸甘油酸变位酶1(PGAM1)基因对食管癌细胞生物学功能的影响及可能机制。方法   收集2016年7月至2017年6月间在我院行手术切除的67例食管癌及对应癌旁正常组织,采用免疫组化SP法检测PGAM1表达并分析其表达与临床病理特征的关系。PGAM1 shRNA(shPGAM1组)或shRNA-NC(NC组)转染至食管癌Eca-109细胞,分析PGAM1基因沉默对Eca-109细胞凋亡和增殖的影响。采用实时荧光定量PCR(QPCR)和Western blotting法检测PGAM1对Akt/mTOR信号通路关键分子的影响。结果   食管癌组织中PGAM1高表达率为58.2%(39/67),高于癌旁组织的31.3%(21/67),差异有统计学意义(P<0.05)。PGAM1表达与临床分期、分化程度、浸润深度有关(P<0.05),而与年龄、性别、淋巴结转移等无关(P>0.05)。shPGAM1组和NC组中PGAM1 mRNA表达量分别为0.48±0.10和1.01±0.14,差异有统计学意义(P<0.05)。MTT法检测结果 显示,培养24、48、72、96 h后,shPGAM1组Eca-109细胞增殖率分别为(87.65±7.42)%、(79.34±9.11)%、(70.17±6.84)%、(60.36±7.95)%,明显低于NC组,差异有统计学意义(P<0.05)。48 h后shPGAM1组和NC组的Eca-109细胞凋亡率分别为(45.36±5.38)%和(24.81±4.67)%,差异有统计学意义(P<0.05);shPGAM1组和NC组Eca-109细胞培养上清的葡萄糖消耗量分别为(56.84±11.35)%和(99.87±10.48)%,shPGAM1组和NC组Eca-109细胞培养上清的乳酸含量分别为(48.02±10.18)%和(99.00±12.35)%,差异均有统计学意义(P<0.05)。shPGAM1组细胞的PTEN表达量高于NC组(P<0.05),而p-Akt、p-mTOR表达量均低于NC组(P<0.05)。结论   PGAM1高表达与食管癌的发生、发展有关,通过激活Akt/mTOR信号通路诱导的Warburg效应,促使肿瘤细胞增殖,抑制其凋亡。

关键词: 食管癌, 磷酸甘油变位酶1(PGAM1), Warburg效应, 糖代谢, Akt/mTOR信号通路

Abstract: Objective  To investigate the effect of silencing phosphoglycerate mutase 1 (PGAM1) gene on the biological function of esophageal carcinoma cells and its possible mechanism. Methods  The expression of PGAM1 was detected by immunohistochemical SP method in 67 fresh esophageal cancer tissues and their adjacent normal tissues from July 2016 to June 2017. In order to analyze the effect of PGAM1 gene silencing on the apoptosis and proliferation of Eca-109 cells, PGAM1 shRNA (shPGM1 group) or shRNA-NC (NC group) was transfected into Eca-109 cells. QPCR and Western blotting were used to detect the effect of PGAM1 on the key molecules in Akt/mTOR signaling pathway. Results The high expression rate of PGAM1 in esophageal carcinoma was 58.2% (39/67), which was higher than that in adjacent tissues (31.3%), and the difference was statistically significant (P<0.05). The expression of PGAM1 was correlated with clinical stage, differentiation degree and depth of invasion (P<0.05), but not with age, sex and lymph node metastasis (P>0.05). The expression of PGAM1 mRNA in shPGAM1 group and NC group were 0.48±0.10 and 1.01±0.14 respectively, and the difference was statistically significant (P<0.05). MTT assay showed that after 24, 48, 72 and 96 hours of culture, the proliferation rates Eca-109 cells in shPGAM1 group were (87.65±7.42)%, (79.34±9.11)%, (70.17± 6.84)% and (60.36±7.95)% respectively, which were significantly lower than those of NC group (P<0.05). The apoptosis rates of Eca-109 cells in shPGAM1 group and NC group were (45.36±5.38)% and (24.81±4.67)% respectively after 48 hours (P<0.05). The content of glucose in culture supernatant of Eca-109 cells in shPGAM1 group and NC group was (56.84±11.35)% and (99.87±10.48)%, respectively. The content of lactic acid in culture supernatant of Eca-109 cells in shPGAM1 group and NC group was (48.02±10.18)% and (99.00±12.35)%, respectively. The difference was statistically significant (P<0.05). The expression of PTEN in shPGAM1 group was higher than that in NC group (P<0.05), but the expression of p-Akt and p-mTOR was lower than that in NC group (P<0.05). Conclusion There are significant evidences that PGAM1 up-regulation would be related with esophageal cancer, which promote the proliferation of Eca-109 cells by activating the Akt/mTOR signaling pathway and Warburg effect.

Key words: Esophageal cancer, Phosphoglycerate mutase 1(PGAM1), Warburg effect, Glucose metabolism, Akt/mTOR signaling pathway

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 陈尚忠. SOX2蛋白在结直肠癌中的表达及临床意义[J]. 临床肿瘤学杂志, 2011, 16(11): 991 .
[2] 史红媛1,田 迎1,胡秋菊1,孟庆欣2,王建东3,卢光明1. 动态增强磁共振评价重组人血管内皮抑素抑制人肺癌裸鼠皮下移植瘤的血管生成[J]. 临床肿瘤学杂志, 2012, 17(1): 19 .
[3]

斯璐,郭军

. 新版中国黑色素瘤诊治指南解读[J]. 临床肿瘤学杂志, 2012, 17(2): 172 .
[4] 马蕾1,金钟2,柳江1. 奥沙利铂联合吉西他滨治疗晚期胆道系统肿瘤的临床观察[J]. 临床肿瘤学杂志, 2012, 17(9): 853 .
[5] 李 津,钟美佐. β-catenin、RIPK4、CDK8在套细胞淋巴瘤中的表达及临床意义[J]. 临床肿瘤学杂志, 2015, 20(3): 233 .
[6] 向作林1,曾昭冲1,吴 铮1. 三维适形加量放疗联合射频热疗治疗局部晚期前列腺癌的临床观察[J]. 临床肿瘤学杂志, 2009, 14(4): 361 .
[7]  徐 燕,王 丹 综述,梁志清 审校. 肿瘤血管异质性的研究进展[J]. 临床肿瘤学杂志, 2009, 14(9): 852 .
[8] 张宏英,陈力舟,林 敏,吕 骁
. Askin瘤报告并文献复习[J]. 临床肿瘤学杂志, 2010, 15(2): 166 .
[9] 李 丽1,2,孔 燕1,2,李海夫1,2,于玮玮1,2,代 杰1,2,迟志宏1,2,斯 璐1,2,盛锡楠1,2,崔传亮1,2,郭 军1,2. 262例中国人黑色素瘤C-KIT基因扩增分析[J]. 临床肿瘤学杂志, 2010, 15(5): 385 .
[10] 冯晓莉1,鲁海珍1,孙耘田1,应建明1,陈 雁2,石素胜1,刘秀云1,郭 蕾1,梁建明3. 肾透明细胞癌中Ki67指数、EGFR表达及DNA倍体的临床意义[J]. 临床肿瘤学杂志, 2009, 14(6): 505 .